# Assessment of genetically modified oilseed rape MON 88302 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21220)

**Authors:** Josep Casacuberta, Francisco Barro, Albert Braeuning, Ruud de Maagd, Michelle M. Epstein, Thomas Frenzel, Jean‐Luc Gallois, Frits Koning, Antoine Messéan, F. Javier Moreno, Fabien Nogué, Giovanni Savoini, Alan H. Schulman, Christoph Tebbe, Eve Veromann, Ana M. Camargo, Paolo Lenzi, Pietro Piffanelli, Tommaso Raffaello

PMC · DOI: 10.2903/j.efsa.2025.9378 · EFSA Journal · 2025-05-13

## TL;DR

This paper assesses the safety of genetically modified oilseed rape MON 88302 for continued use in food and feed, finding no new risks.

## Contribution

The study confirms the original safety conclusions for MON 88302 using updated data and no new hazards were identified.

## Key findings

- No new hazards were identified in the renewal dossier for MON 88302.
- Updated analyses did not reveal modified exposure or scientific uncertainties.
- The original risk assessment conclusions remain valid for MON 88302.

## Abstract

Following the submission of dossier GMFF‐2023‐21220 under Regulation (EC) No 1829/2003 from Bayer CropScience LP, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the herbicide‐tolerant genetically modified oilseed rape MON 88302, for food and feed uses, excluding cultivation within the European Union. The data received in the context of this renewal application contained post‐market environmental monitoring reports, an evaluation of the literature retrieved by a scoping review, a search for additional studies performed by or on behalf of the applicant and updated bioinformatics analyses. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in oilseed rape MON 88302 considered for renewal is identical to the sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in renewal dossier GMFF‐2023‐21220 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on oilseed rape MON 88302.

## Full-text entities

- **Chemicals:** GMFF-2023-21220 (-)
- **Species:** Brassica napus (oilseed rape, species) [taxon 3708]
- **Cell lines:** MON 88302 — Homo sapiens (Human), Extrarenal rhabdoid tumor, Cancer cell line (CVCL_M846)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12070034/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12070034/full.md

---
Source: https://tomesphere.com/paper/PMC12070034